Myocardial infarction after aspirin cessation in stable coronary artery disease patients

1994, Collaborative overview of randomised trials of antiplatelets therapy. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients, Br Med J, 308, 81, 10.1136/bmj.308.6921.81

Fitzgerald, 1983, Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man, J Clin Invest, 71, 676, 10.1172/JCI110814

Fitzgerald, 1986, Platelet activation in unstable coronary disease, N Engl J Med, 315, 983, 10.1056/NEJM198610163151602

Lam, 1994, Platelet aggregation, coronary disease progression and future coronary events, Am J Cardiol, 73, 333, 10.1016/0002-9149(94)90004-3

Vial, 1991, Rebound elevation in urinary thromboxane B2 and 6-keto-PFF1 alpha exacerbation alter aspirin withdrawal, Prostaglandin Thromboxane Leukot Res, 21A, 157